The Pharmacogenomics Data Are In So Why Is Adoption Still La

Pharmacogenomics is gaining support in mental health and polypharmacy, where the data make a strong case for improvements in clinical and economic outcomes.

Related Keywords

United States , Kentucky , Nijenhuis , Overijssel , Netherlands , Dutch , Americans , Raymond Lorenz , Health Aff , Dutch Pharmacogenetics Working Group , Kentucky Teacher Retirement Association , Coriell Life Sciences , Clinical Pharmacogenetics Implementation Consortium , Medication Cost Savings For Mental Health Care , Medication Management Program , Quest Diagnostics , Mental Health Gene , Clinical Pharmacogenetics Implementation Consortium Guideline , Mental Health Gene Drug , Medicare Advantage , Depressive Symptom Remission , Systematic Review , Controlled Clinical , Clin Pharmacol , Adverse Drug Reactions , Published March , Combinatorial Pharmacogenomics , Medication Cost Savings , Mental Health Care , Primary Care , Med Res , World Impact , Many Americans , Service Sectors Used , Behavioral Primary , Prof Psychology Res , Published July , Occup Environ , Publish Ahead , Pharmacogenomic Biomarkers , Pharmacogenetics Working Group , Pharmacogenetics Implementation Consortium , Serotonin Reuptake Inhibitor , Eurj Hum , Phenytoin Dosing ,